SARS-CoV-2 Infection and Cardiovascular Disease: COVID-19 Heart
- PMID: 32601020
- PMCID: PMC7274628
- DOI: 10.1016/j.hlc.2020.05.101
SARS-CoV-2 Infection and Cardiovascular Disease: COVID-19 Heart
Abstract
Coronavirus disease (COVID-19) is a serious illness caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The symptoms of the disease range from asymptomatic to mild respiratory symptoms and even potentially life-threatening cardiovascular and pulmonary complications. Cardiac complications include acute myocardial injury, arrhythmias, cardiogenic shock and even sudden death. Furthermore, drug interactions with COVID-19 therapies may place the patient at risk for arrhythmias, cardiomyopathy and sudden death. In this review, we summarise the cardiac manifestations of COVID-19 infection and propose a simplified algorithm for patient management during the COVID-19 pandemic.
Keywords: COVID; CV disease; Coronavirus; Myocarditis.
Copyright © 2020 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.
Figures



Similar articles
-
COVID-19 and the Heart.Circ Res. 2020 May 8;126(10):1443-1455. doi: 10.1161/CIRCRESAHA.120.317055. Epub 2020 Apr 7. Circ Res. 2020. PMID: 32252591 Review.
-
A care pathway for the cardiovascular complications of COVID-19: Insights from an institutional response.Am Heart J. 2020 Jul;225:3-9. doi: 10.1016/j.ahj.2020.04.024. Epub 2020 May 3. Am Heart J. 2020. PMID: 32417526 Free PMC article.
-
Acute kidney injury in COVID-19: a case-report.Int Urol Nephrol. 2020 Nov;52(11):2213-2214. doi: 10.1007/s11255-020-02635-3. Epub 2020 Sep 8. Int Urol Nephrol. 2020. PMID: 32897492 Free PMC article. No abstract available.
-
Advances in the relationship between coronavirus infection and cardiovascular diseases.Biomed Pharmacother. 2020 Jul;127:110230. doi: 10.1016/j.biopha.2020.110230. Epub 2020 May 13. Biomed Pharmacother. 2020. PMID: 32428835 Free PMC article. Review.
-
Myocarditis in Multisystem Inflammatory Syndrome in Children Associated With Coronavirus Disease 2019.Cardiol Rev. 2020 Nov/Dec;28(6):308-311. doi: 10.1097/CRD.0000000000000341. Cardiol Rev. 2020. PMID: 32941261 Review.
Cited by
-
Pediatric endocrinopathies related to COVID-19: an update.World J Pediatr. 2023 Sep;19(9):823-834. doi: 10.1007/s12519-022-00662-x. Epub 2022 Dec 8. World J Pediatr. 2023. PMID: 36480134 Free PMC article.
-
Improvement in the diagnosis and practices of emergency healthcare providers for heat emergencies after HEAT (heat emergency awareness & treatment) an educational intervention: a multicenter quasi-experimental study.BMC Emerg Med. 2023 Jan 31;23(1):12. doi: 10.1186/s12873-022-00768-5. BMC Emerg Med. 2023. PMID: 36721088 Free PMC article.
-
N-3 polyunsaturated fatty acids block the trimethylamine-N-oxide- ACE2- TMPRSS2 cascade to inhibit the infection of human endothelial progenitor cells by SARS-CoV-2.J Nutr Biochem. 2022 Nov;109:109102. doi: 10.1016/j.jnutbio.2022.109102. Epub 2022 Jul 8. J Nutr Biochem. 2022. PMID: 35817244 Free PMC article.
-
Infective endocarditis presentations during the COVID-19 pandemic: have they paid an untold toll?Glob Cardiol Sci Pract. 2024 Mar 3;2024(2):e202411. doi: 10.21542/gcsp.2024.11. eCollection 2024 Mar 3. Glob Cardiol Sci Pract. 2024. PMID: 38746068 Free PMC article.
-
Presentation and pathophysiology of neuro-COVID.Drugs Context. 2021 Aug 12;10:2021-6-5. doi: 10.7573/dic.2021-6-5. eCollection 2021. Drugs Context. 2021. PMID: 34457013 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous